[1] Schwartz SL,Hemostasis surgical bleeding,and transfusion.In:Schwartz SL,Shires GT,Spencer FC, eds. Principles of surgery.5thed.New York:McGraw-Hill, 1989: 105-135.
[2] 杨德林,张妍,岳武,等.几种止血材料在肝脏创伤中的应用研究[J].中华创伤杂志,2004,20(2):111-112.
[3] Wu J,Jin Y,Zhang J,et al.Hemostatic Techniques Following Multilevel PosteriorLumbar Spine Surgery: A Randomized Control Trial.J Spinal Disord Tech. 2013. [Epub ahead of print]
[4] 李学军,孙园园.不同生物止血材料研究进展及复合型止血材料的临床应用[J].中国组织工程研究与临床康复, 2011,15(51): 9671-9674.
[5] 施子禄,林沁,陈建.局部止血药物与材料的临床应用概况[J].中国药房,2007,18(4):307.
[6] 汪向飞,张晓丹,周汉新.生物医用可吸收止血材料的研究与临床应用[J].中国组织工程研究与临床康复, 2010,14(21):3973-3976.
[7] Ziv-Polat O,Topaz M,Brosh T,et al.Enhancement of incisional wound healing by thrombin conjugated iron oxide nanoparticles. Biomaterials.2010;31(4):741-747.
[8] 武继民,李荣,王岩.胶原海绵作为止血和创面敷料的临床实验[J].生物医学工程与临床,2003,9(7):152-154.
[9] 肖荣冬,翁国星.胶原/透明质酸膜与明胶海绵支架材料力学及组织相容性的比较[J].中国组织工程研究, 2012,16(25):4637- 4643.
[10] 何艳新,刘超.可吸收材料生物蛋白胶及明胶海绵在肝部分切除的应用[J].中国组织工程研究,2012,16(12):2180-2182.
[11] 张巍,张元和.脂肪干细胞与可吸收明胶海绵的组织相容性[J].中国组织工程研究, 2013,17(40):7047-7053.
[12] 康佐文,时凯,黄国章.立止血的酶学特性及其作用机理[J].蛇志, 2001,13(1):59-61.
[13] Itoh N,Tanaka N,Misi S,et al.Molecular cloning and sequence analysis of cDNA for Batroxobin,a thrombin-like snake venom enzyme.J Biol Chem.1987;262(7):3132-3135.
[14] 邢宝才,宋军民.外科引流的合理应用[J].中国实用外科杂志, 2007, 27(1):48-50.
[15] 赵士海,胡庆柳,钟志勇,等.胶原/纤维蛋白止血效果观察[J].中国比较医学杂志,2010,20(5):61-65.
[16] 霍雷,阮文华,丁志良,等.新型止血材料SURGICELTM和明胶海绵在神经外科手术中的应用[J].中国组织工程研究, 2012, 16(3): 551-554.
[17] Alam HB,Burris D,DaCorta JA,et al.et al.Hemorrhage control in the battlefield: role of new hemostatic agents.Mil Med. 2005; 170(1):63-69.
[18] 潘华,周元聪,杨冠珍,等.蝮蛇类凝血酶基因的分析及表达研究[J].生物化学与生物物理学报,1999,31(1):79-82.
[19] Hofmann H,Bon C.Blood coagulation induced by the venom of Bothrops atrox. 2. Identification, purification, and properties of two factor X activators.Biochemistry. 1987;26(3):780-787.
[20] 安海水,姚军,王红杰.血凝酶不同给药方法用于脊柱手术止血效果[J].中国新药与临床杂志,2004,23(7):390-392.
[21] 何锡强,汪蓓,赵辉,等.注射用血凝酶对髋关节置换术患者围术期出凝血功能影响的研究[J].中华创伤外科杂志, 2004,20(11): 685-687.
[22] Guan LF,Chi CW,Yuan M.Study on the thrombin-like enzyme preferentially releasing fibrinopeptide B from the snake venom of Agkistrodon halys Pallas.Thromb Res. 1984;35(3): 301-310.
[23] Zhang Y,Lee WH,Gao R,et al.Effects of Pallas ' viper . (Effects of Pallas' viper (Agkistrodon halys pallas) venom on blood coagulation and characterization of a prothrombin activator.Toxicon.1998;36(1):143-152.
[24] Alam HB,Burris D,DaCorta JA,et al.Hemorrhage control in the battlefield:role of new hemostatic agents.Mil Med. 2005; 170(1): 63-69.
[25] Belman A,Daya M,Stevens M,et al.From the battlefield to the street-experience of a suburban fire/EMS agency with chitosan dressing. Hemostatic Management. 2006;12(3): 46-47.
[26] Petrowsky H,Demartines N,Rousson V,et al. Evidence-basedvalue of prophylactic drainage in gastro in test inal surgery a systematic reiew and metaeta-analyses. Ann Surg.2004;240(6):1074-1084.
[27] 梅枭雄,范承启,张继超,等.医疗条件缺乏环境下的创伤止血药物(材料)研究现状[J].中国药房,2012,23(13):1232-1233.
[28] 卢斌,钱利强,章志量.壳聚糖止血机理及应用进展研究[J].健康研究,2010,30(1):55-58.
[29] Pozza M,Millner RW.Celox (chitosan) for haemostasis in massive traumatic bleeding: experience in Afghanistan.Eur J Emerg Med.2011;18(1):31-33.
[30] 张伟.几丁质及其衍生物促进创面愈合的作用[J].中国矫形外科杂志,2000,7(3):277.
[31] 庞迪,张亚新.新型生物止血材料-医用生物蛋白胶临床应用的效果观察[J].山东生物医学工程,2003,22(1):44-45.
[32] 王莲莲,汤智怡,罗娜.生物止血材料在妇产科手术中的应用[J].中国组织工程研究与临床康复,2011,15(29):5441-5444.
[33] 周忠笑,魏晰麟,姚建茹,等.生物止血敷料及纱布在外科伤口中的应用评价[J].中国组织工程研究与临床康复, 2010,14(51): 9635-9638.
[34] 张德兴,何忠杰.伤口止血材料研究进展[J].中国急救医学, 2005, 5(25):353-355.
[35] 邓春梅,何兰珍,杨丹,等.壳聚糖-明胶海绵伤口敷料的毒理学评价[J].毒理学杂志,2007,21(1):76-77
[36] 首家保,陈彬,芦慎,等.不同敷料修复创面的实验研究及临床应用评价[J].中国组织工程研究,2012,16(8):1479-1482.
[37] 王建,葛宝丰,刘兴炎,等.战伤止血方法及材料研究进展[J].人民军医,2008,51(1):5-6.
[38] Fiss I,Danne M,Stendel R.Use of gelatin-thrombin matrix hemostatic sealant in cranial neurosurgery.Neurol Med Chir (Tokyo). 2007;47(10):462-467.
[39] 王勇,陆伟.体内可吸收止血材料研究及临床应用[J].生物医学工程学杂志,2009,26(4):922-926.
[40] 孙鸿涛,裴国献,王运斗,等.伤口急救保护剂对猪肢体创伤创面的止血研究[J].中华创伤骨科杂志,2003,5(4):291-295.
[41] Gazzeri R,Galarza M,Neroni M,et al.Hemostatic matrix sealant in neurosurgery: a clinical and imaging study.Acta Neurochir (Wien).2011;153(1):148-154.
[42] Mathiasen RA,Cruz RM.Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.Otolaryngol Head Neck Surg. 2004;131(5):601-605.
[43] Nasso G,Piancone F,Bonifazi R,et al.Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. Ann Thorac Surg.2009;88(5):1520-1526.
[44] Weaver FA,Hood DB,Zatina M,et al.Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery.Ann Vasc Surg.2002;16(3):286-293.
[45] Yao HH,Hong MK,Drummond KJ.Haemostasis in neurosurgery: what is the evidence for gelatin-thrombin matrix sealant? J Clin Neurosci.2013;20(3):349-356. |